You need to be logged in to view this video

Takeaways from the MicroCap Biotech Conference

Released on Friday, October 5, 2018BIOTECH

John moderated a panel of Biotech CEOs earlier this week (October 1st) at the MicroCap Conference in NYC. The panel covered a variety of current topics of interest to investors including:

  • The role of pricing and transparency in health care
  • Why are we seeing new initiative like Civica Rx and the JP Morgan/Berkshire Hathaway/Amazon collaboration?
  • How do we address the fast growth of healthcare costs in the United States
  • How the FDA is changing
  • Immuno-oncology and the impact of new biologics in this space
  • Trends in Biotech-focused Venture Capital
  • Availability of capital in the biotech space and China's new role
  • Potential benefits from AI and technology on the healthcare space
  • Regulatory trends and how they impact capital decisions

  • John will share with MoneyShow what biotech CEOs are thinking and what investors are asking about these topics.

    John Vandermosten
    Zacks Investment Research, Senior Biotechnology Research Analyst

    Trending Now

    Filter By Category
    Filter By Keywords